Surface analysis of PEGylated nano-shields on nanoparticles installed by hydrophobic anchors

Pharmaceutical Research

Volumn 30, Issue 7, 2013, Pages 1758-1767

  Ebbesen, M F ^a   Whitehead, B ^a   Ballarin Gonzalez, B ^a   Kingshott, P ^b   Howard, K A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

nanoparticles; PEG; stealth; surface analysis; XPS

Indexed keywords

COPOLYMER; NANOPARTICLE; POLYGLACTIN;

ARTICLE; CELL INTERACTION; DIFFUSION; DRUG DELIVERY SYSTEM; EMULSION; FLOW CYTOMETRY; HYDRODYNAMICS; HYDROPHOBICITY; LIGHT SCATTERING; MACROPHAGE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

ANIMALS; CELL LINE; CELL SURVIVAL; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; MICE; NANOPARTICLES; PARTICLE SIZE; PHOTOELECTRON SPECTROSCOPY; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYGLYCOLIC ACID; SURFACE PROPERTIES;

EID: 84878828219     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1018-3     Document Type: Article

References (26)

1. Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials. 2009;30(14):2790-8.
2. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm. 1999;187(2):143-52. (Pubitemid 29443894)
3. Walker KJ, Turkes AO, Turkes A, Zwink R, Beacock C, Buck AC, et al. Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex®). J Endocrinol. 1984;103(2):R1-4.
4. Kappy M, Stuart T, Perelman A, Clemons R. Suppression of gonatropin-secretion by a long-acting gonatropin-releasing hormone analog (Leuprolide acetate, Lupron depot) in children with precocious puberty. J Clin Endocrinol Metab. 1989;69(5):1087-9. (Pubitemid 19261845)
5. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93-102. (Pubitemid 41773257)
6. Betancourt T, Byrne JD, Sunaryo N, Crowder SW, Kadapakkam M, Patel S, et al. PEGylation strategies for active targeting of PLA/PLGA nanoparticles. Journal of Biomedical Materials Research Part A. 2009;91A(1):263-76.
7. Meng FH, Engbers GHM, Feijen J. Polyethylene glycol-grafted polystyrene particles. Journal of Biomedical Materials Research Part A. 2004;70A(1):49-58. (Pubitemid 38849812)
8. Hermanson GT. Bioconjugate Techniques. Bioconjugate Techniques (Second Edition). 2 ed. New York: Academic Press; 2008.
9. Wattendorf U, Merkle HP. PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci. 2008;97(11):4655-69.
10. Davis SS, Illum L, Neal JC, Garnett MC, Stolnik S. Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres. Pharm Res. 1998;15(2):318-24. (Pubitemid 28144247)
11. Hamad I, Al-Hanbali O, Hunter AC, Rutt KJ, Andresen TL, Moghimi SM. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano. 2010;4(11):6629-38.
12. Neal JC. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. J Pharm Sci. 1998;87(10):1242-8. (Pubitemid 28455616)
13. Halperin A. Polymer brushes that resist adsorption of model proteins: â design parameters. Langmuir. 1999;15(7):2525-33.
14. Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm. 2008;349(1-2):249-55. (Pubitemid 350299701)
15. Chan JM, Zhang L, Yuet KP, Liao G, Rhee J-W, Langer R, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30(8):1627-34.
16. Betancourt T, Shah K, Brannon-Peppas L. Rhodamine-loaded poly(lactic-co-glycolic acid) nanoparticles for investigation of in vitro interactions with breast cancer cells. J Mater Sci: Mater Med. 2009;20(1):387-95.
17. Fischer S, Foerg C, Ellenberger S, Merkle HP, Gander B. One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. J Control Release. 2006;111(1-2):135-44. (Pubitemid 43290002)
18. Liu Y, Li K, Liu B, Feng S-S. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials. 2010;31(35):9145-55.
19. Farokhzad OC, Cheng JJ, Teply BA, Sherifi I, Jon S, Kantoff PW, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A. 2006;103(16):6315-20.
20. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263(5153):1600-3. (Pubitemid 24128361)
21. Gref R, Minamitake Y, Peracchia M, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263(5153):1600-3. (Pubitemid 24128361)
22. Andersen MO, Lichawska A, Arpanaei A, Jensen SMR, Kaur H, Oupicky D, et al. Surface functionalisation of PLGA nanoparticles for gene silencing. Biomaterials. 2010;31(21):5671-7.
23. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1-16. (Pubitemid 44902565)
24. Wang Y, Wang R, Lu X, Lu W, Zhang C, Liang W. Pegylated phospholipids-based self-assembly with water-soluble drugs. Pharm Res. 2010;27(2):361-70.
25. Goodwin J. Colloids and Interfaces with Surfactants and Polymers: An Introduction. West Sussex: John Wiley & Sons; 2004.
26. Shin S-B, Cho H-Y, Kim D-D, Choi H-G, Lee Y-B. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery. Eur J Pharm Biopharm. 2010;74(2):164-71.